Highly-sensitive blood test detects hidden traces of pancreatic cancer
Northwestern Medicine scientists have demonstrated that a highly sensitive blood test can detect traces of pancreatic cancer missed…
The Drug That Bought My Father More Time Didn’t Happen by Accident
I still remember the day my father and I sat in his oncologist’s office and first heard the…
Daraxonrasib’s Phase 3 Pancreatic Cancer Survival Data Might Change The Case For Investing In RVMD
Revolution Medicines recently reported detailed Phase 3 RASolute 302 data showing once-daily oral daraxonrasib delivered unprecedented overall and…
Study identifies new therapeutic candidate for KRAS-driven pancreatic cancer
A new research paper was published in Volume 17 of Oncotarget on June 3, 2026, titled “The anticancer effects of PCAIs…
Adult weight gain strongly linked to higher obesity-related cancer risk
New research presented at this year’s European Congress on Obesity (ECO 2026) in Istanbul, Turkey (12-15 May) shows…
How FDA Expanded Access for Daraxonrasib and Phase 3 Survival Data At Revolution Medicines (RVMD) Has Changed Its Investment Story
Revolution Medicines recently secured FDA clearance for an expanded access program for its investigational pancreatic cancer drug daraxonrasib,…
Researchers identify new treatment vulnerabilities in pancreatic cancer progression
The review offers important insights for patients and families by explaining why pancreatic cancer has proven so resistant…
Six genes found to connect pancreatic cancer with metabolic dysfunction
New research shows that the same genes are active in pancreatic cancer, obesity and diabetes, helping to explain…
Alpha Tau Announces 100% Local Disease Control Rate and
– 100% local disease control rate achieved in evaluable patients in pooled analysis of two first-in-human trials of…
Man, 43, Went to the Doctor for a Stomach Bug. 6 Months Later, He Was Dead from the ‘Silent Killer’
NEED TO KNOW Michael Armishaw was diagnosed with stage 4 pancreatic cancer weeks after experiencing initial stomach pain…
AI model detects pancreatic cancer years before clinical diagnosis
An AI model (REDMOD) can pick up the very early subtle tissue changes of pancreatic ductal adenocarcinoma, the…
Metabolic pathways drive progression from pancreatic lesions to cancer
Pancreatic ductal adenocarcinoma is the most common type of pancreatic cancer and has a low five-year survival rate.…